EFA presented the burden of atopic eczema in Europe at EADV Congress
On 7-10th September, an EFA delegation attended Congress was the annual opportunity for EFA to liaise with the scientific community, learn and get up...
EFA brought the asthma and COPD expectations of digital health to HIMSS 2022 (DIG_IT)
In May this year EFA had the opportunity to attend the European Health Conference & Exhibition (HIMMS) for the first time, as a newly established partner...
EFA calls on the EU for a strong support of health policies through 2023
EFA contributed to the consultation on the EU4Health Programme budget with calls for patient-centred investment in prevention and care for respiratory...
EFA recommendations to the Codex revision Revision of allergen labelling in the General Standard for the Labelling of Prepacked Food (GSLPF)
Between May and July, the Codex Alimentarius Commission (CAC), a WHO-FAO body setting international food standards, organised a stakeholder consultation...
EFA response to the public consultation on a European Health Data Space (EHDS)
On 3rd May 2022, the European Commission presented its proposal for a Regulation on the European Health Data Space (EHDS), an initiative which aims at...
EFA participated in the International Respiratory Coalition summit
In June, EFA participated in the International Respiratory Coalition (IRC) summit organised by the European Respiratory Society (ERS). The IRC is a new...
EFA participates in EMA workshop on integrating patient experience in drug development
In September, the European Medicines Agency (EMA) organised the first in-person multi-stakeholder workshop since the pandemic on a crucial topic for...
GUIDE Asthma: EFA launches new survey on asthma patient resources
In 2022, EFA is focusing on defining gaps in asthma patients and carers knowledge and information to empower asthma patients’ in better self-management...
EFA Isabel Proaño elected as Board Member of the European Patient’s Forum
The allergy and respiratory community is honoured to have EFA nominee elected to join the European Patients’ Forum (EPF) Board for a period of two...
European Commission responds to Parliamentary Question on allergy prevention, support and research policies
In the context of the highly anticipated 'Healthier Together – EU Non‑Communicable Diseases' (NCDs) initiative and the Commission’s pledge to work...
EFA participates in IMI-ImmUniverse annual meeting
On 13-14th June, EFA attended the annual meeting of ImmUniverse, an Innovative Medicines Initiative (IMI) research funded project aiming at improving...
FFAAIR presented research results on smoking cessation at ERS Congress 2022
EFA Member French Federation of Friends of Respiratory or Disabled Patients’ Associations (FFAAIR) submitted research on the “Barriers to early diagnosis...
Living with Allergy Association set sail for World Atopic Eczema Day
With chronic diseases such as atopic eczema (AE), patients often feel alone and helpless. The communication between the doctors and the patients weakens...
aha! Swiss Allergy Centre campaigned for World Atopic Eczema Day
EFA Member aha! Swiss Allergy Centre launched an awareness raising campaign for World Atopic Eczema Day, which took place throughout the week of 12 September....
aha! Swiss Allergy Center represented EFA at launch of Global Dermatology Coalition
EFA Partner GlobalSkin hosted an event with two non-state actors in official relations with the World Health Organization (WHO), the International League...
Allergy and Me seeks support to optimise website
EFA Member Allergy and Me, Serbia, is seeking support from the EFA network, partners and industry to improve their website through optimisation of existing...
EFA response to the European Commission proposal for a Regulation on Fluorinated Greenhouse Gases
After a consultative process which started in 2020, the European Commission published in June 2022 its proposal for a Regulation on Fluorinated Greenhouse...
PRESS RELEASE: Unite to recognise the many burdens of Atopic Eczema
September 14th 2022 - World Atopic Eczema Day 2022. Today, World Atopic Eczema Day, the patient communities across the globe join forces to raise awareness...
Joint Statement on the ongoing Energy Performance of Buildings Directive (EPBD) review
The European Federation of Allergy and Airways Diseases Patients’ Associations and the Federation of European Heating, Ventilation and Air Conditioning...
PRESS RELEASE: Europe reaches consensus on the burden of Atopic Dermatitis/Eczema
Milan, Italy – 7 September 2022. Following one year of in-depth discussions around the reality of Atopic Dermatitis/Eczema (AD/E), patients and doctors...